Loading...
Changes in Blood Pressure and Urine Albumin-Creatinine Ratio in a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
PURPOSE: To compare blood pressure and urine albumin-creatinine ratio over time for participants receiving aflibercept, bevacizumab, or ranibizumab. METHODS: Preplanned secondary analyses from a randomized trial comparing aflibercept, bevacizumab, and ranibizumab for diabetic macular edema (DME). Th...
Na minha lista:
| Udgivet i: | Invest Ophthalmol Vis Sci |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
The Association for Research in Vision and Ophthalmology
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5837671/ https://ncbi.nlm.nih.gov/pubmed/29625440 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1167/iovs.17-22853 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|